Market Capitalization

An exclusive, invite-only conference in NYC highlights the explosive growth and strategic importance of GP stakes, gathering the industry's elite players.

The global investment bank's strategic move to join the 24X National Exchange signals a major validation for the extended-hours trading model.

Veteran ad expert Dave Saunders names the champions and flops of Super Bowl LX, revealing what works in an era of AI and celebrity-packed commercials.

Waters finalized its $18.8B merger with BD's units, doubling its size. But investor concerns over near-term performance sent shares tumbling.

A major defense order for infrared cameras highlights LightPath's strategic growth and the critical push for secure, domestic military manufacturing.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

After a year-long restructuring, SVCV launches asset manager NextRock to acquire 100 companies and build a cross-industry empire from finance to fashion.

Retired Four-Star General Jack Keane joins REalloys to build a US rare earth supply chain, as a fintech firm pivots to tackle national security risks.

With five conferences in its sights, Voyager Therapeutics is making a major push to win over investors ahead of a pivotal year for its neurological pipeline.

A new report reveals AI-themed ads failed to connect with viewers, while heartfelt, human-centric stories from brands like the NFL and Budweiser won the night.

After a decade transforming the UK's largest care provider, Safanad's sale to Welltower signals a major shift in global investment towards the Gulf.

As ReNew prepares its Q3 FY26 report, all eyes are on the energy giant. Will its performance validate India's green transition and its own manufacturing bet?

IN8bio promotes Kate Rochlin to President, signaling a strategic push to advance its promising gamma-delta T cell pipeline amid a challenging market.

Swvl's new healthcare mobility contract in Saudi Arabia marks a strategic shift to high-value enterprise deals. Can this move stabilize the firm?

Private equity firm Haveli Investments acquires kids' app giant Budge Studios, signaling a strategic bet on the future of digital play and licensed content.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.

Leading Italian publisher adopts The Washington Post's Arc XP platform, betting on AI and data to navigate a radically changing media landscape.

Global giant CSL taps Swiss biotech Memo Therapeutics in a landmark deal, signaling a major shift from plasma to lab-grown immunotherapies.